Pinned Tweet
$VERU
Enobosarm is an oral drug in the muscle waste and weight loss category that is in Phase 2 trials with some of the best looking safety and muscle retention/weight loss data in the category. $VERU completed a supply agreement with $NVO in June so the giants are at least paying attention. $LLY bought bimagrumab's parent company in 2023 for $2 billion after phase 2 results, which the CEO of $VERU has made clear is their plan. Market is much larger now and the drug is oral instead of IV. Less than a $50 million market cap. 14 million float.
New Obesity Treatment Burns More Energy Instead of Cutting Appetite | Knowridge
Powerful weight-loss medicines have changed the treatment of obesity and type 2 diabetes in only a few years.
Drugs such as Ozempic, Wegovy, Mounjaro and Zepbound can help people eat less, lose substantial amounts of weight and improve blood sugar control.
Researchers are now exploring a very different strategy: helping the body use more energy rather than mainly reducing how much food a person eats.
A research team at the University of California, Berkeley, has studied a compound called 5-tetradecyloxy-2-furoic acid, or TOFA.
In experiments with mice, TOFA increased energy use while also improving several signs of poor metabolic health. The research was published in the journal Science Advances.
Obesity develops when the body stores more energy than it uses over a long period.
Biology is much more complicated than simply counting calories, because appetite, hormones, genes, sleep, activity and the environment all influence body weight.
Even so, researchers often describe weight control as involving two broad sides: energy coming in through food and energy being used by the body.
Today’s highly effective GLP-1-based medicines mainly work on the first side. They affect signals involved in appetite and digestion, helping many people feel full sooner and eat less.
This can produce major health benefits, but reduced food intake may also make it harder for some people to consume enough protein and other nutrients.
Weight loss can also include loss of muscle as well as fat. Maintaining muscle is important because muscle supports strength, movement, balance and healthy aging. Researchers are therefore interested in treatments that could reduce body fat while better preserving lean tissue.
Senior author Anders Näär, a professor of metabolic biology and nutrition at UC Berkeley, and his colleagues decided to investigate the other side of the energy equation.
Instead of concentrating on appetite, they studied whether metabolism could be shifted so that cells used more energy. Their experiments centered on TOFA, a compound that scientists have known about since the 1970s.
TOFA belongs to a group of compounds that can block enzymes called acetyl-CoA carboxylases, or ACCs. These enzymes help the body make fats such as fatty acids and triglycerides. Blocking them can reduce fat production, which has made ACC inhibitors interesting candidates for treating metabolic diseases.
However, earlier ACC inhibitors have faced an important problem. Some have caused triglycerides in the blood to rise, an unwanted effect because high triglyceride levels can contribute to cardiovascular risk. Although several ACC inhibitors reached clinical testing, none has been approved for treating metabolic disease.
The Berkeley researchers found that TOFA appeared to do more than simply reduce the body’s production of fat. It also activated two cellular switches called PPAR-alpha and PPAR-delta. These switches control genes that help cells take in fats and use them as fuel.
This combination appeared to create a coordinated change in metabolism. The cells made less fat while also increasing their ability to burn available fuel. In the mice, energy expenditure increased by as much as 18% without an increase in physical activity or body temperature.
The researchers also reported several improvements related to diabetes and metabolic disease. TOFA improved the animals’ response to insulin and helped control blood glucose. It lowered triglycerides and improved signs of fatty liver disease, a condition in which excess fat accumulates in the liver.
The effect on body composition was especially interesting. Obese mice treated with TOFA lost body fat without a significant reduction in lean muscle mass. If a similar effect could eventually be achieved safely in people, preserving muscle could be an important advantage during weight loss.
First author Justin Y. Lee, who carried out the work while a doctoral student at Berkeley, said TOFA seemed to produce a broader metabolic response rather than simply blocking fat production.
The researchers tested this idea by giving mice two separate compounds, one designed to reduce fat production and another designed to increase energy use. That combination did not produce the same overall metabolic benefits as TOFA alone.
The team then asked whether the new approach might work alongside existing weight-loss medicines. They combined TOFA with GLP-1-based drugs including semaglutide and tirzepatide in mice. The combined treatments produced greater improvements in weight, blood glucose, insulin and triglycerides than either approach used alone.
This suggests that the strategies could potentially complement each other. A GLP-1 medicine could reduce energy intake by lowering appetite, while a TOFA-like treatment could increase the amount of energy the body uses. Näär said the researchers view TOFA as a possible partner for GLP-1 therapy rather than a replacement.
The findings are promising, but there is a major reason for caution: the experiments were conducted in animals. A drug that works well in mice may behave very differently in humans. Researchers still need to determine whether TOFA is safe, what dose might be appropriate and whether the metabolic benefits would occur in people.
Increasing energy expenditure also needs careful study because metabolism affects many organs and biological systems. A treatment that changes fat production and fuel use could have unexpected effects that are not obvious in short animal experiments. Long-term safety would therefore be just as important as weight loss.
The researchers have founded a company called ReRx Therapeutics to help move the work toward possible human treatment.
Before TOFA or a related compound could become a medicine, it would need extensive laboratory testing followed by carefully controlled clinical trials. That process can take years, and many promising experimental drugs never reach patients.
Overall, the study offers an interesting new direction for obesity research. Rather than relying only on appetite suppression, it suggests that scientists may be able to target the body’s energy use while preserving more lean tissue.
The strongest finding is the combination of fat loss, better glucose control and higher energy expenditure in mice, but it remains far too early to know whether the same benefits will appear safely in humans.
The research is important because future obesity treatment may not depend on a single biological pathway. Combining medicines that influence different parts of metabolism could potentially produce stronger results or address some weaknesses of current treatments.
For now, however, TOFA should be viewed as an experimental research compound, not an available alternative to approved weight-loss medicines.
Read more:
knowridge.com/2026/08/new-ob…
4
558
BM retweeted
🇺🇸🇮🇷The White House has asked the Pentagon and intelligence experts for their assessments of how Iran would respond to each of the strike scenarios the U.S. military has prepared, according to the two sources
🇺🇸🇮🇷The White House has asked whether any of the options would avoid triggering a devastating Iranian retaliation against the Gulf countries' oil and gas facilities
🇺🇸🇮🇱🇮🇷Trump weighs strikes on Iran as Israel warns of chemical weapons. My story on @axios
axios.com/2026/11/19/trump-i…
BM retweeted
I would expect B300 pricing to continue declining.
A staggering number of neoclouds have approached us @liquidcompute looking to remarket long-term B300 capacity originally committed to Chinese-affiliated offtakers into the US and Western Europe due to concerns of stricter legislation regarding compute servicing to China.
liquidcompute.com/share/b300…
BM retweeted
Gemini 4 Neon even surpassed Fable 5.2 in coding agent index and sits 6 points ahead of the yesterday released GPT-6.2 Astra.
BM retweeted
SAUDI ARABIA EXPECTS HOUTHI WAR TO CONTINUE WELL INTO 2027
Saudi Arabia expects its conflict with Yemen's Houthi rebels to extend well into 2027, Reuters reports, citing two Western officials familiar with Saudi discussions.
Riyadh reportedly wants its allies to secure additional battlefield gains before entering negotiations with the Houthis.
The outlook suggests no near-term diplomatic breakthrough, raising the prospect of prolonged instability in Yemen and continued geopolitical risks around the Red Sea and regional shipping routes.
BM retweeted
Fed’s Waller says central bank may need to ‘shock people’ with half-point rate hike - CNBC
Cost Pressures Already in Pipeline to Fuel Higher Inflation - WSJ
BM retweeted
Who knows where $NVDA is going, but I would not want to be short with this monster buyback looming
Never go full tard......NVDA beats on earnings and raises guidance. Buybacks coming.......might have to unwound the short or end up drowning in Muddy Waters.
Muddy Waters is short $NVDA
A woman identified as Cenly Chen, referred to in some photograph tags as Cenly Puri, has been photographed in public between 2024 to 2026 with Ajay K. Puri. Until this June, Mr. Puri was likely the third most senior executive at NVDA, behind only Jensen Huang and Colette Kress. His title was EVP Worldwide Field Operations and his total compensation was slightly above Ms. Kress’ in fiscal years 2024 to 2026.4 Mr. Puri was one of only five NVDA executives named in the 2026 Proxy.
Separately, consolidated class action complaint filed against Super Micro Computer Inc. in October 2026 alleges that former SMCI Chief Growth Officer, a woman named Cenly Chen, “managed [SMCI’s] acquisition of GPU chips from NVIDIA” and “decided how to distribute [NVDA GPUs] among Super Micro’s customers.” In March this year, the U.S. indicted three individuals associated with SMCI, including a co-founder, for illegally selling at least approximately $2.5 billion of SMCI servers with NVDA GPUs to end customers in China through a Southeast Asian front company. Referring to the ex-SMCI executive, the class action complaint alleges that there was “no way Cenly Chen lacked knowledge of [SMCI’s] illicit sales.”
Mr. Puri left NVDA in late June 2026, and the former SMCI executive named Cenly Chen left SMCI in late April or early May 2026. Mr. Puri continues to serve in a senior advisory role to NVDA.
Nobody by the name of Cenly Chen has been indicted or otherwise accused of criminal conduct by any government. The allegations in the class action are unproven.
The question is whether the woman identified as Cenly Chen or Cenly Puri in photographs with Mr. Puri is the same Cenly Chen formerly employed by SMCI.
BM retweeted
on $RYTM - Lilly has submitted a $150/shr . AZN still involved
M&A blog
BM retweeted
‼️ Most of the Nvidia hardware bought by Megaspeed’s Indonesian entity was likely transported to China, possibly via private jet after arriving in Indonesia ‼️
Indonesian police have searched the office of PT Megaspeed International Indonesia, a locally incorporated company owned by Singapore-based Megaspeed International.
The move, carried out earlier in 2026, was part of an inquiry requested by the FBI to trace Nvidia chips bought by Megaspeed.
Officers from Indonesian National Police’s Criminal Investigation Department (Bareskrim) who inspected the premises found server racks at the site but no GPUs. The racks appeared never to have been unpacked or used, suggesting that the chips were never installed there.
The raid, which was conducted before the recent Jensen Huang scandal, was the first known enforcement action in Indonesia linked to the case.
The official alleged that most of the Nvidia hardware bought by Megaspeed entities was likely shipped to Indonesia. Investigators believe much of it was then sent to China, possibly by private jet.
Shipping records show Megaspeed's Indonesian subsidiary imported Nvidia hardware between 2024 and 2026, including H100 processors and related components. The hardware was delivered in shipments from suppliers including Gigabyte subsidiary Giga Computing.
PT Megaspeed International Indonesia has a listed address on the fifth floor of Cyber 1 building at No. 8 Jalan Kuningan Barat in South Jakarta, but the company is not on the building’s tenant list. A building receptionist said that PT Megaspeed instead operates out of the office of PT MettaDC Teknologi Indonesia (MettaDC), an Indonesian carrier-neutral data center and sovereign AI infrastructure provider.
An officer at MettaDC confirmed that Megaspeed uses its office, which is enclosed by tinted glass walls near the lift on that floor.
The officer said Megaspeed also rents space in the Jababeka Industrial Estate in Cikarang, Bekasi, West Java. The facility is owned by PT HDC, a hyperscale data centre operator.
Megaspeed's Indonesian subsidiary was created in May 2024.
Singapore's home affairs ministry said 🇺🇸 Commerce Department's Bureau of Industry and Security carried out a shipment verification check at Megaspeed in June 2025.
US officials suspect Megaspeed’s former managing director, Alice Huang, who had a relationship with Jensen Huang, of passing information to Beijing. Jensen Huang resigned on Nov 12.
The Huang scandal has sparked calls for a clampdown on the export of cutting-edge US chips, which would complicate Southeast Asia’s AI infrastructure build-out.
🇺🇸 Commerce Department is working on rules that would add Malaysia, Indonesia and Singapore to a group of countries subject to export restrictions.
These rules would make it compulsory for companies exporting advanced chips such as Nvidia’s Blackwell series to those countries to get a license that would prohibit Chinese customers from remotely accessing the computing power.
Singapore and the US have discussed the Megaspeed case at a senior-level meeting in Washington, with both countries committing to continue discussions on the matter.
In Indonesia, Nvidia-linked data centers, which are clustered in West Java and Batam, with Jakarta as the main hub, could come under greater scrutiny. Much of the capacity for these centres is still being planned or under construction.
In Purwakarta, West Java, Raia Grid, a joint digital infrastructure venture of Indonesian investment conglomerate Arsari Group and telecommunications provider Indosat, is due to begin assembling 140 to 150 Nvidia GPUs in Dec.
In Batam, Australian AI start-up Firmus and Singapore-based data center operator DayOne are planning a 360MW Nvidia AI Factory campus. It is set to receive up to 170,000 GPUs in 2027 and 2028, with initial operations targeted for 2027.
Nvidia is reportedly exploring a US$4.5 billion investment in Batam.
straitstimes.com/asia/se-asi…
reuters.com/world/asia-pacif…
💥 Thanks to Chinese customers, Malaysia could become the second-largest data center hub in the world, after Virginia, packed with top-of-the-line Nvidia chips China’s leading AI companies can use to challenge American dominance.
Jensen Huang built a multibillion-dollar business to feed the ravenous appetite of Chinese customers for American chips, cultivating a network of Asian partners who could serve the Chinese far from Washington. He made a friend of President Trump and lobbied Washington hard to keep the backdoor to China open.
China jumped to take advantage of the avenues Trump didn’t close. Its AI developers exploited the Nvidia chips they desperately needed to catch up with America’s leaders, either using smuggled chips or accessing them remotely in places like Malaysia.
Revelations about Huang’s affair with an executive at one of those Asian partners now threaten to implode the entire lucrative ecosystem he built in Asia to get China the chips it needed.
Nvidia reported $12.4 billion in China revenue in the six months through July 26 of this year, or 7% of its global revenue, and analysts say that countless more billions of dollars ultimately trace back to Chinese customers. It’s been estimated that more than 20% of Nvidia’s revenues last fiscal year were driven by China.
In Southeast Asia, Chinese demand is responsible for the massive scale of data centers.
Megaspeed, Alice Huang’s company, arranged to send nearly $12 billion worth of top-of-the-line Nvidia chips to companies in China between Mar 2024 and June 2025.
Shipment records show orders for several hundred thousand export-controlled chips, though the records don’t show how much of the hardware was actually delivered or where it originated.
Huang was unapologetic in pushing to sell as many chips to Chinese customers as possible even as his American customers were racing to stay ahead of Chinese rivals. The CEO’s effort to persuade Trump to allow direct exports of Nvidia’s high-end chips to China was mostly unsuccessful, despite policy flip-flops and headlines on the subject. But the workarounds, including remote access to overseas data centers, made up much of the gap.
Huang’s logic: Better to keep customers hooked on American tech and keep high-paying jobs at home than give an opening to rival Chinese chip makers such as Huawei.
Chinese companies quickly figured out the best two routes — smuggling and remote access — to sidestep export bans. By physically bringing Nvidia chips into China, Chinese AI developers keep their computing power nearby, making it easier to test, train and fine-tune powerful AI models.
While Megaspeed’s Alice Huang was carrying on an affair with Jensen Huang, her firm sent chips to buyers in China that had years of business ties with local tech companies.
A case in March gives a glimpse of smuggling tactics. A co-founder of Super Micro Computer, a longtime Nvidia partner, and others participated in a conspiracy to ship servers to a Southeast Asian company, then onward to China. When inspectors from Super Micro asked to pay a visit to the Southeast Asian company’s facilities to ensure the servers it ordered were in its possession, the conspirators had a problem: the servers had already been sent to China. To pass their audits, the conspirators arranged to build a Potemkin server warehouse that supposedly contained Nvidia chips. To fool a visiting US government inspector, a hair dryer was used to remove and affix serial number stickers.
Such prosecutions likely touch only a small fraction of smugglers. Still, with the legal risks growing, many Chinese companies are spending billions of dollars on a legal alternative.
Data centers outside China can freely import Nvidia chips and rent the computing power to Chinese customers. In May 2025, the Trump administration opened the floodgates to the tactic by revoking a Biden administration plan to limit how many chips countries in Southeast Asia and
1/n
wsj.com/tech/jensen-huang-ba…
BM retweeted
Department of Commerce designates si export packages: unveils next phase of American si exports program
BM retweeted
$VERU ICYMI: Ahead of next week's ObesityWeek 2026 conference (Nov 14–17 in D.C.), Veru confirmed CSO Dr. Gary Barnette will deliver an oral podium presentation on Mon, Nov 16 at 5:15 PM EST.
They're presenting new post-hoc physical function results for enobosarm in older patients (≥65) on GLP-1 therapy from the positive Phase 2b QUALITY study.
With the Phase 2b PLATEAU trial fully enrolled (239 patients) and interim data on deck for Q1 2027, Monday's readout is a key scientific spotlight on the muscle-preservation thesis. Worth keeping on the radar heading into Monday's close.
Wall St. Trader: You've Been Lied To About Trading! I Built A 10Yr Track... youtu.be/9K4XnEtTa9Q?si=jyte… via @YouTube
5
BM retweeted
BREAKING: Trump abandons talks with Iran, declaring the US no longer needs a deal with Tehran.
"We don't need a deal with Iran. Those days have long since passed. We've got their money, hundreds of billions of dollars, and we've got their Strait," he says.
Iran told Qatar in the past 24 hours that it would not negotiate over its nuclear program at all under any circumstances.
Qatar then relayed the message to the US, prompting Trump to say he no longer needs a deal, senior officials involved in the negotiations say.
Trump also told Vance to now "focus his complete and total attention on the massive corruption."






























